medigraphic.com
SPANISH

Archivos de Medicina de Urgencia de México

ISSN 2594-3006 (Electronic)
ISSN 2007-1752 (Print)
Archivos de Medicina de Urgencia de México
  • Contents
  • View Archive
  • Information
    • General Information        
    • Directory
  • Publish
    • Instructions for authors        
  • medigraphic.com
    • Home
    • Journals index            
    • Register / Login
  • Mi perfil

2025, Number 2-3

<< Back Next >>

Arch Med Urg Mex 2025; 17 (2-3)

Lipid emulsions in the poisoned patient: A case series

Gómez-Ramírez LA, Baena-Gallego F, Torres-Zapata A, Montoya-Zapata LM, Berrouet-Mejía MC
Full text How to cite this article 10.35366/122687

DOI

DOI: 10.35366/122687
URL: https://dx.doi.org/10.35366/122687

Language: Spanish
References: 19
Page: 175-179
PDF size: 242.84 Kb.


Key words:

lipid emulsions, intoxications, cardiotoxicity, neurotoxicity.

ABSTRACT

Background: severe poisonings by lipophilic substances represent a therapeutic challenge in emergency settings. Lipid emulsions (LE) are formulations of triglycerides and phospholipids that have gained relevance as a rescue therapy. Their key mechanism of action is the lipid sink effect (lipid sequestration) complemented by metabolic effects and the modulation of ion channels, offering cardiovascular and neurological benefits.
Case Presentation: this series describes two adult patients poisoned by multiple lipophilic medications (antidepressants, antipsychotics, anticonvulsants, or beta-blockers). Both cases presented with severe cardiovascular and neurological toxicity (e.g., complex arrhythmias, status epilepticus) refractory to supportive measures and conventional pharmacological therapies.
Results: following the standardized administration of 20% lipid emulsions, both patients showed a significant hemodynamic (e.g., arrhythmia reversal) and neurological (e.g., seizure cessation) improvement. Both cases had a favorable clinical outcome, with complete resolution of the acute toxicity.
Conclusions: the administration of lipid emulsions proved to be a useful rescue therapy in patients with severe toxicity from non-anesthetic xenobiotics refractory to initial management. Its use, although based on low-quality evidence, should be reserved for scenarios


REFERENCES

  1. Weinberg GL, VadeBoncouer T, Ramaraju GA, Garcia-Amaro MF,Cwik MJ. Pretreatment or resuscitation with a lipid infu- sion shiftsthe dose-response to bupivacaine-induced asystole in rats. Anesthesiology.1998; 88:1071-5.

  2. Weinberg GL, Laurito CE, Geldner P, Pygon BH, Burton BK. Malignantventricular dysrhythmias in a patient with isovaleric acidemiareceiving general and local anesthesia for suction lipectomy. J ClinAnesth. 1997;9(8):668-70.

  3. Cave G, Harvey M, Willers J, Uncles D, Meek T, Picard J, et al.LIPAEMIC Report: Results of Clinical Use of Intravenous LipidEmulsion in Drug Toxicity Reported to an Online Lipid Registry. JMed Toxicol. junio de 2014;10(2):133-42.

  4. Fettiplace MR, Weinberg G. The mechanisms underlying lipid resuscitationtherapy. Reg Anesth Pain Med. 2018; 43:138-49

  5. Kostic MA, Gorelick M. Review of the use of lipid emulsion in nonlocalanesthetic poisoning. Pediatr Emerg Care. 2014; 30:427-33

  6. Mottram AR, Valdivia CR, Makielski JC. Fatty acids antagonizebupivacaine-induced I(Na) bloc- kade. Clin Toxicol (Phila). 2011;49:729-33,

  7. Steinberg HO, Paradisi G, Hook G, Crowder K, Cronin J, BaronAD. Free fatty acid elevation impairs insulin-mediated vasodi- lationand nitric oxide production. Diabetes. 2000; 49:1231-8.

  8. Fettiplace MR, Kowal K, Ripper R, et al. Insulin signaling in bupivacaine-induced cardiac toxicity: Sensitization during recovery andpotentiation by lipid emulsion. Anesthesiology. 2016; 124:428-42

  9. García-Ramos S, Fernandez I, Zaballos M. Lipid emulsions in thetreatment of intoxications by local anesthesics and other drugs.Review of mechanisms of action and recommendations for use.Rev Esp Anestesiol Reanim (Engl Ed). 14 de junio de 2021;S0034-9356(21)00143-2.

  10. Hoegberg LCG, Gosselin S. Lipid resuscitation in acute poisoning:after a decade of publications, what have we really learned?Curr Opin Anaesthesiol. 2017;30(4):474-9. Doi: 10.1097/ACO.0000000000000484.

  11. Turner-Lawrence DE, Kerns Ii W. Intravenous fat emulsion: a potentialnovel antidote. J Med Toxicol. 2008;4(2):109-14.

  12. Bania TC, Chu J, Perez E, Su M, Hahn IH. Hemodynamic Effectsof Intravenous Fat Emulsion in an Animal Model of Severe VerapamilToxicity Resuscitated with Atropine, Calcium, and Saline. AcadEmerg Med. 2007;14(2):105-11.

  13. Cave G, Harvey MG, Castle CD. The role of fat emulsion therapyin a rodent model of propranolol toxicity: A preliminary study. JMed Toxicol. 2006;2(1):4-7.

  14. Estrada-Atehortúa AF, Berrouet-Mejía MC. Uso de emulsioneslipídicas en el paciente intoxicado: una perspectiva desde el serviciode urgencias. Curare. 2017;3(2): 1-7.

  15. American College of Medical Toxicology. ACMT position statement:interim guidance for the use of lipid resuscitation therapy. JMed Toxicol. 2011 Mar;7(1):81-2.

  16. Estrada-Atehortua AF; Quiroz-Alvarez JE; Arroyave-Peña T. Usode emulsiones lipídicas en intoxicación por antidepresivos tricí-clicos desde el servicio de urgencias: Una serie de casos. Rev.Toxicol (2022) 39: 36 - 40

  17. Rotella JA, Greene SL, Koutsogiannis Z, Graudins A, HungLeang Y, Kuan K, Baxter H, Bourke E, Wong A. Treatment forbeta-blocker poisoning: a systematic review. Clin Toxicol (Phila).2020;58(10):943-983.

  18. Clemons J, Jandu A, Stein B, Chary MA. Efficacy of lipid emulsiontherapy in treating cardiotoxicity from diphenhydramine ingestion:a review and analysis of case reports. Clin Toxicol (Phila).2022;60(5):550-558.

  19. Gosselin S, Hoegberg LCG, Hoffman RS, Graudins A, St-OngeM, Lavergne V, et al. Evidence-based recommendations on theuse of intravenous lipid emulsion therapy in poisoning. Clin Toxicol(Phila). 2016;54(10):899-921.




2020     |     www.medigraphic.com

Mi perfil

C?MO CITAR (Vancouver)

Arch Med Urg Mex. 2025;17